<VariationArchive VariationID="440854" VariationName="NM_005651.4(TDO2):c.491dup (p.Ile165fs)" VariationType="Duplication" Accession="VCV000440854" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2017-10-09" MostRecentSubmission="2017-10-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="434499" VariationID="440854">
      <GeneList>
        <Gene Symbol="TDO2" FullName="tryptophan 2,3-dioxygenase" GeneID="6999" HGNC_ID="HGNC:11708" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q32.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="155903696" stop="155920406" display_start="155903696" display_stop="155920406" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NW_003315914.1" start="68319" stop="85029" display_start="68319" display_stop="85029" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="156824844" stop="156841557" display_start="156824844" display_stop="156841557" Strand="+" />
          </Location>
          <OMIM>191070</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005651.4(TDO2):c.491dup (p.Ile165fs)</Name>
      <CanonicalSPDI>NC_000004.12:155910082:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q32.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="155910082" stop="155910083" display_start="155910082" display_stop="155910083" variantLength="1" positionVCF="155910082" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="156831234" stop="156831235" display_start="156831234" display_stop="156831235" variantLength="1" positionVCF="156831234" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>I165fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.156831236dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.156831236dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.155910084dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.155910084dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005651.4" sequenceAccession="NM_005651" sequenceVersion="4" change="c.491dup" MANESelect="true">
            <Expression>NM_005651.4:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005642.1" sequenceAccession="NP_005642" sequenceVersion="1" change="p.Ile165fs">
            <Expression>NP_005642.1:p.Ile165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA3118779" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="191070.0001" DB="OMIM" />
        <XRef Type="rs" ID="767123432" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005651.4(TDO2):c.491dup (p.Ile165fs) AND Familial hypertryptophanemia" Accession="RCV000509047" Version="1">
        <ClassifiedConditionList TraitSetID="7820">
          <ClassifiedCondition DB="MedGen" ID="C2931837">Familial hypertryptophanemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-10-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-10-09" MostRecentSubmission="2017-10-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28285122</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7820" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2204" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hypertryptophanemia</ElementValue>
                <XRef ID="MONDO:0010907" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2871" />
                <XRef ID="2871" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2224" DB="Orphanet" />
              <XRef ID="C2931837" DB="MedGen" />
              <XRef ID="MONDO:0010907" DB="MONDO" />
              <XRef Type="MIM" ID="600627" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1173856" SubmissionDate="2017-10-04" DateLastUpdated="2017-10-09" DateCreated="2017-10-09">
        <ClinVarSubmissionID localKey="191070.0001_HYPERTRYPTOPHANEMIA (1 patient)" title="TDO2, 1-BP DUP, NT491_HYPERTRYPTOPHANEMIA (1 patient)" />
        <ClinVarAccession Accession="SCV000606825" DateUpdated="2017-10-09" DateCreated="2017-10-09" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 28-year-old woman with congenital hypertryptophanemia (HYPTRP; 600627), Ferreira et al. (2017) identified compound heterozygosity for a 1-bp duplication (c.491dup) in the TDO2 gene, causing a frameshift predicted to result in a premature termination codon (Ile165AspfsTer12) and a protein only 43% of its normal length, and a c.324G-C transversion, resulting in a met108-to-ile (M108I; 191070.0002) substitution at a highly conserved residue. The proband's unaffected parents were each heterozygous for 1 of the mutations. The duplication was reported in 1 of 121,218 ExAC chromosomes, and the M108I mutation was not found in the ExAC database. The frameshift variant did not express soluble protein. Analysis of the M108I variant demonstrated reduced catalytic efficiency compared to wildtype, as well as reduced affinity for L-tryptophan at the high-affinity noncatalytic exo L-trp binding site, which was predicted to result in a greatly accelerated rate of degradation.</Attribute>
              <Citation>
                <ID Source="PubMed">28285122</ID>
              </Citation>
              <XRef DB="OMIM" ID="600627" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TDO2" />
          </GeneList>
          <Name>TDO2, 1-BP DUP, NT491</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT491</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191070.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERTRYPTOPHANEMIA (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

